Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEnquest Regulatory News (ENQ)

Share Price Information for Enquest (ENQ)

Share Price is delayed by 15 minutes
Get Live Data
23.85    -0.30 (-1.24%)
Bid:
23.80
Ask:
23.90
Spread: 0.10 (0.42%)
Market Cap: £443.87m
ENQ Live PriceLast checked at - London Stock Exchange

Intraday Enquest Share Chart

Transaction in Own Shares

23 Sep 2024 07:00

RNS Number : 1348F
EnQuest PLC
23 September 2024
 

FOR IMMEDIATE RELEASE 23 September 2024

 

ENQUEST PLC ("EnQuest" or "the Company")

TRANSACTIONS IN OWN SHARES

EnQuest PLC (the "Company") announces that, on 20 September 2024, it purchased the following number of its ordinary shares of 5 pence each (the "Ordinary Shares") through Merrill Lynch International ("Merrill Lynch"). Such purchase was effected pursuant to the instructions issued by the Company in accordance with the share repurchase arrangements entered into with Merrill Lynch, as announced on 29 April 2024.

Aggregated information of Ordinary Shares purchased on 20 September 2024 according to each trading venue:

Venue

Weighted average price paid per share (GBp)

Aggregate number of shares purchased

Lowest price paid per share (GBp)

Highest price paid per share (GBp)

London Stock Exchange

11.40

599,000

11.20

11.60

Chi-X

11.40

30,032

11.30

11.54

BATS

11.35

14,221

11.30

11.48

Turquoise

-

0

-

-

Total (all venues)

11.39

643,253

11.20

11.60

 

Since 29 April 2024, the Company has purchased 33,295,887 Ordinary Shares at a cost (including dealing and associated costs) of £4,489,790.95. Of those shares, 25,000,000 Ordinary Shares have been retained in Treasury and will be issued in due course to the Company's Employee Benefit Trust and 8,295,887 Ordinary Shares have been purchased for cancellation.

Following the cancellation of the purchased shares, there will be 1,907,628,452 Ordinary Shares in issue and 25,000,000 Shares in Treasury. The total voting rights in the Company will accordingly be 1,882,628,452. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Disclosure Guidance and Transparency Rules.

A full breakdown of the individual trades made by Merrill Lynch on behalf of the Company as part of the share repurchase programme is attached to this document.

Attachment: http://www.rns-pdf.londonstockexchange.com/rns/1348F_1-2024-9-21.pdf

 

LEI: 2138008LJU6WFQWOXJ73

 

This announcement does not constitute, or form part of, an offer or any solicitation of an offer for securities in any jurisdiction.

 

Enquiries:

 

EnQuest plc +44 (0)20 7925 4900

Kate Christ, Company Secretary

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSBXGDCUDDDGSB
Date   Source Headline
31st Oct 20189:38 amRNSTotal Voting Rights
24th Oct 201812:11 pmRNSDirector/PDMR Shareholding
23rd Oct 20184:47 pmRNSDirector/PDMR Shareholding
22nd Oct 20186:14 pmRNSResults of Rump Placing
22nd Oct 20187:00 amRNSResult of Rights Issue
4th Oct 20187:00 amRNSMagnus and Thistle Options exercised
2nd Oct 20183:12 pmRNSDirector/PDMR Shareholding
2nd Oct 20187:00 amRNSAdmission of Nil Paid Rights
1st Oct 20182:55 pmRNSResults of General Meeting
25th Sep 20187:00 amRNSSwedish Issue Price
24th Sep 20181:43 pmRNSDirector/PDMR Shareholding
7th Sep 20187:00 amRNSMagnus Acquisition and Rights Issue
7th Sep 20187:00 amRNSHalf-year Report
29th Aug 20187:00 amRNSKraken FPSO settlement agreement
31st Jul 20182:17 pmRNSNotice to holders of the Company's Retail Notes
7th Jun 201811:24 amRNSReport on Payments to Govts
24th May 20184:39 pmRNSResult of AGM
24th May 20187:00 amRNSOperations Update
27th Apr 20184:37 pmRNSDirector/PDMR Shareholding
24th Apr 20182:27 pmRNSDirector/PDMR Shareholding
19th Apr 20184:00 pmRNSNotice of AGM and Report & Accounts
29th Mar 20188:57 amRNSDirector/PDMR Shareholding
20th Mar 20187:00 amRNSFull Year Results
21st Feb 20183:56 pmRNSAdmission to Trading
19th Feb 20187:00 amRNSOperations Update
16th Feb 20184:51 pmRNSReplacement: Released in Error
15th Feb 20189:07 amRNSPublication of Final Terms
31st Jan 20187:00 amRNSAGREEMENT WITH BP ON THISTLE DECOMMISSIONING
29th Jan 201810:22 amRNSNotice to holders of the Company's Retail Notes
25th Jan 20183:34 pmRNSHolding(s) in Company
10th Jan 20183:59 pmRNSTotal Voting Rights
8th Jan 20187:00 amRNSBoard Appointment
11th Dec 20177:00 amRNSDirectorate Change
1st Dec 20177:00 amRNSCompletion of Acquisition
30th Nov 20177:00 amRNSOperational Update
26th Oct 20177:00 amRNSLiquidity enhanced by over $100 million
24th Oct 201710:51 amRNSAllotment and Listing of Shares
26th Sep 20173:02 pmRNSDirector/PDMR Shareholding
22nd Sep 201712:58 pmRNSPublication of a Prospectus
13th Sep 20173:48 pmRNSDirector/PDMR Shareholding
7th Sep 20177:00 amRNSBoard Appointment
7th Sep 20177:00 amRNSHalf Year Results
23rd Aug 20177:00 amRNSOperations update
31st Jul 20174:34 pmRNSNotice to holders of the Company's Retail Notes
29th Jun 20179:00 amRNSDirectorate Change
26th Jun 20177:00 amRNSKraken First Oil
21st Jun 20174:14 pmRNSReport on Payments to Govts
25th May 20174:44 pmRNSBoard Appointment
25th May 20174:39 pmRNSResult of AGM
25th May 20177:00 amRNSOperational Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.